Environmental and Experimental Factors Affecting Efficacy Testing of Nonporous Plastic Antimicrobial Surfaces

Test methods for efficacy assessment of antimicrobial coatings are not modelled on a hospital environment, and instead use high humidity (>90%) high temperature (37 °C), and no airflow. Therefore, an inoculum will not dry, resulting in an antimicrobial surface exhibiting prolonged antimicrobial activity, as moisture is critical to activity. Liquids will dry quicker in a hospital ward, resulting in a reduced antimicrobial efficacy compared to

Antimicrobial Peptides and their Potential to Combat Antimicrobial Resistance Opinion on the Use Of Antimicrobial Coatings In Health-Care Settings

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Maria Olivia Pereira, Assistant Professor University of Minho Department of Biological Engineering Braga, Portugal, Professor in Biomedical Engineering Principal Investigator in the Biofilm Group. This presentation can be also viewed in SlideShare

AMR in Grece: View from the Veterinary Sector

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Dr. Theofilos Papadopoulos, DVM, MSc, MPH, PhD, Aristotle’s University of Thessaloniki, Veterinary Research Institute of Thessaloniki This presentation can be also viewed in SlideShare.

Novel Antimicrobial Strategies to Combat Biomaterial‐Associated Infections Opinion on the use of AMCs in health‐care setting

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Martijn Riool, Postdoc at University of Amsterdam, AMC ‐ CRANIOSAFE (NL STW) Note: this presentation can be also viewed in SlideShare

Emergence and spread of antibiotic resistance

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Tanel Tenson,  Professor in the technology of antimicrobial compounds University of Tartu, Estonia. Note: this presentation can be also viewed in SlideShare

Trends on Health-Care Associated Infections and Infection Control in Estonia and in Europe

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Pille Märtin, Infection control doctor West-Tallinn Central Hospital, Chief specialist Dep. Of Communicable Diseases surveillance and control Health Board of Estonia   Note: this presentation can be also viewed in SlideShare

AMR: view from the hospital’s laboratory. Usage of AMCs in health‐care settings

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017  by Siiri Kõljalg MD, PhD  University of Tartu,  Tartu University Hospital Note: this presentation can be also viewed in SlideShare

Use of antibiotics in health care and problems with AMR in Estonia: comparison with Europe

Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Irja Lutsar MD, PhD Professor of Medical Microbiology  University of Tartu